Clinical Trial Update: Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on sequential immunization with a recombinant COVID-19 vaccine (CHO cells) and an inactivated COVID-19 vaccine (Vero cells) in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections

Drugs mentioned

• inactivated COVID-19 vaccine (Vero cells)
• recombinant COVID-19 vaccine (CHO cells)

Snippet

Sponsor: National Vaccine and Serum Institute, China | Conditions: COVID-19 Pneumonia, Coronavirus Infections | Phase 2 | Status: UNKNOWN